Skip to content
Screener

Organogenesis Holdings Inc. ORGO Q4 2025 Annual earnings

Reported February 26, 2026 · After market close

Revenue$225.1MBeat by $52.4M
EPS$0.31Beat by $0.10
Revenue estimate$172.7M
EPS estimate$0.22

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$52.1M
EPS estimate-$0.18

Financials

Q4 2025

Income statement

See full
Revenue$225.6M+78.1%
Operating income$63.3M—
Net income$43.7M+470%
EPS (diluted)$0.27—

Balance sheet

See full
Cash & equivalents$93.7M-30.9%
Total debt$91.6M-35.2%
Total equity$300.1M+14.2%
Total assets$598.7M+20.3%

Cash flow

See full
CapEx$4.7M+38.4%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$657.4M+63.4%
Enterprise value$655.3M+60.5%
P/E17.8×-450×
P/S1.2×+0.3×

Profitability

See full
Operating margin7.9%—
Net margin6.6%+6.4pp

Returns & leverage

See full
Return on equity13.2%+12.8pp
Debt / equity0.3×-0.2×
Current ratio3.6×-0.1×

Segments

By product

See full
Grant$536.0K—

FAQ

When did Organogenesis Holdings Inc. report Q4 2025 earnings?
Organogenesis Holdings Inc. (ORGO) reported Q4 2025 earnings on February 26, 2026 after market close.
What were Organogenesis Holdings Inc.'s Q4 2025 revenue and EPS?
Organogenesis Holdings Inc. reported revenue of $225.1M and eps of $0.31 for Q4 2025.
Did Organogenesis Holdings Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $172.7M by $52.4M. EPS beat the consensus estimate of $0.21 by $0.10.
How did Organogenesis Holdings Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 77.7% from $126.7M a year earlier and eps grew 675.0% from $0.04.
Where can I find Organogenesis Holdings Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-064270) and the 10-K periodic report (0001193125-26-076730) directly on SEC EDGAR. The filing index links above go to sec.gov.